1. Home
  2. RVMD vs DBX Comparison

RVMD vs DBX Comparison

Compare RVMD & DBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • DBX
  • Stock Information
  • Founded
  • RVMD 2014
  • DBX 2007
  • Country
  • RVMD United States
  • DBX United States
  • Employees
  • RVMD N/A
  • DBX N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • DBX Computer Software: Prepackaged Software
  • Sector
  • RVMD Health Care
  • DBX Technology
  • Exchange
  • RVMD Nasdaq
  • DBX Nasdaq
  • Market Cap
  • RVMD 8.7B
  • DBX 9.2B
  • IPO Year
  • RVMD 2020
  • DBX 2018
  • Fundamental
  • Price
  • RVMD $40.16
  • DBX $31.11
  • Analyst Decision
  • RVMD Strong Buy
  • DBX Hold
  • Analyst Count
  • RVMD 13
  • DBX 8
  • Target Price
  • RVMD $65.15
  • DBX $28.86
  • AVG Volume (30 Days)
  • RVMD 1.3M
  • DBX 2.7M
  • Earning Date
  • RVMD 02-24-2025
  • DBX 02-13-2025
  • Dividend Yield
  • RVMD N/A
  • DBX N/A
  • EPS Growth
  • RVMD N/A
  • DBX 9.62
  • EPS
  • RVMD N/A
  • DBX 1.76
  • Revenue
  • RVMD $742,000.00
  • DBX $2,539,600,000.00
  • Revenue This Year
  • RVMD N/A
  • DBX $2.69
  • Revenue Next Year
  • RVMD $1,855.56
  • DBX $0.58
  • P/E Ratio
  • RVMD N/A
  • DBX $17.65
  • Revenue Growth
  • RVMD N/A
  • DBX 3.01
  • 52 Week Low
  • RVMD $26.56
  • DBX $20.68
  • 52 Week High
  • RVMD $62.40
  • DBX $33.43
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 31.31
  • DBX 64.26
  • Support Level
  • RVMD $39.48
  • DBX $29.01
  • Resistance Level
  • RVMD $42.97
  • DBX $30.32
  • Average True Range (ATR)
  • RVMD 1.48
  • DBX 0.51
  • MACD
  • RVMD -0.07
  • DBX 0.02
  • Stochastic Oscillator
  • RVMD 13.59
  • DBX 99.29

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

About DBX Dropbox Inc.

Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB. The company was founded in 2007 and was a pioneer in cloud storage and cross-platform file syncing. Utilizing inorganic and organic means, the firm has been working on diversifying its product mix and pivoting away from the cloud-storage space.

Share on Social Networks: